Cancer Genomics - Proteomics: 18 (5)

September-October 2021; Volume 18,Issue 5

Reviews

You have access
MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets
ULRICH H. WEIDLE and ADAM NOPORA

Cancer Genomics & Proteomics September 2021, 18 (5) 591-603; DOI: https://doi.org/10.21873/cgp.20283
You have access
Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease
VASILEIOS C. PEZOULAS, ORSALIA HAZAPIS, NEFELI LAGOPATI, THEMIS P. EXARCHOS, ANDREAS V. GOULES, ATHANASIOS G. TZIOUFAS, DIMITRIOS I. FOTIADIS, IOANNIS G. STRATIS, ATHANASIOS N. YANNACOPOULOS and VASSILIS G. GORGOULIS

Cancer Genomics & Proteomics September 2021, 18 (5) 605-626; DOI: https://doi.org/10.21873/cgp.20284

Articles

You have access
Delayed MRI Enhancement of Colorectal Cancer Liver Metastases Is Associated With Metastatic Mutational Profile
ARUN SETH, YUTAKA AMEMIYA, HELEN CHEUNG, EUGENE HSIEH, CALVIN LAW and LAURENT MILOT

Cancer Genomics & Proteomics September 2021, 18 (5) 627-635; DOI: https://doi.org/10.21873/cgp.20285
You have access
Multikinase-Inhibitor Screening in Drug-resistant Osteosarcoma Patient-derived Orthotopic Xenograft Mouse Models Identifies the Clinical Potential of Regorafenib
TAKASHI HIGUCHI, KENTARO IGARASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, MICHAEL BOUVET, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN

Cancer Genomics & Proteomics September 2021, 18 (5) 637-643; DOI: https://doi.org/10.21873/cgp.20286
You have access
Paclitaxel Impedes EGFR-mutated PC9 Cell Growth via Reactive Oxygen Species-mediated DNA Damage and EGFR/PI3K/AKT/mTOR Signaling Pathway Suppression
MD MOHIUDDIN and KAZUO KASAHARA

Cancer Genomics & Proteomics September 2021, 18 (5) 645-659; DOI: https://doi.org/10.21873/cgp.20287
You have access
The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells
MD MOHIUDDIN and KAZUO KASAHARA

Cancer Genomics & Proteomics September 2021, 18 (5) 661-673; DOI: https://doi.org/10.21873/cgp.20288
You have access
SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer
JOO KYUNG NOH, SEON RANG WOO, MIYONG YUN, MIN KYEONG LEE, MOONKYOO KONG, SOONKI MIN, SU IL KIM, YOUNG CHAN LEE, YOUNG-GYU EUN and SEONG-GYU KO

Cancer Genomics & Proteomics September 2021, 18 (5) 675-684; DOI: https://doi.org/10.21873/cgp.20289
You have access
Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Uterine Cervix: Clinicopathological and Molecular Characteristics With Special Emphasis on the First Description of Consistent Programmed Death-ligand 1 (PD-L1) Over-expression
SANGJOON CHOI, SO-WOON KIM and HYUN-SOO KIM

Cancer Genomics & Proteomics September 2021, 18 (5) 685-698; DOI: https://doi.org/10.21873/cgp.20290

Main menu

User menu

Search

Table of Contents

Reviews

Articles

In this issue

Issue highlights

Jump to